Objectives: Recent studies have shown that estrogens alone or in associatio
n with progestins can exert an antioxidant effect on Low-Density Lipoprotei
n (LDL) and lipids of platelet membranes. It has been demonstrated that the
oxidative modification of LDLs also involving the formation of lipid perox
ides, exerts several biological effects that may contribute to the onset an
d progression of cardiovascular diseases. Therefore, the aim of our study w
as to evaluate the effect of short-term treatment with oral estrogens alone
and estrogens plus progestin on endogenous and copper-induced serum levels
of lipid peroxides in postmenopausal women. Methods: Thirty-nine postmenop
ausal women were randomly divided into three groups: group I was treated wi
th oral conjugated equine estrogens (CEE) for 21 days; group II received or
al CEE for 21 days and, after 14 days of this treatment, 5 mg/day of medrog
estone was added for 7 days; group III did not receive any therapy (control
s). Endogenous and copper-induced serum levels of lipid peroxides were dete
rmined before and after 21 days of treatment in the two treated groups and
in the control group. Results: The serum endogenous levels of lipid peroxid
es in postmenopausal women did not change after short-term treatment with h
ormone replacement therapy, Moreover, copper-induced serum levels of lipid
peroxides significantly decreased after therapy in both groups I and II. Co
nclusions: Our data show that hormone replacement therapy (HRT) inhibits li
pid peroxidation and may play a role in preventing cardiovascular diseases.
(C) 1999 Elsevier Science Ireland Ltd. All rights reserved.